| Stage | DVN | % of rev | EOG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.9B | 100.00% | $8.3B | 100.00% | EOG ×1.21 |
| Gross profit | $3.4B | 48.89% | $7.1B | 85.72% | EOG +36.8pp |
| Operating income | $1.4B | 20.51% | $3.6B | 43.17% | EOG +22.7pp |
| Pre-tax income | $1.3B | 18.25% | $3.6B | 42.90% | EOG +24.7pp |
| Net income | $1.0B | 14.69% | $2.8B | 33.48% | EOG +18.8pp |
| Stage | DVN | EOG | Gap · A − B |
|---|---|---|---|
| Revenue | $6.9B100.00% | $8.3B100.00% | EOG ×1.21 |
| Gross profit | 48.89%$3.4B | 85.72%$7.1B | EOG +36.8pp |
| Operating income | 20.51%$1.4B | 43.17%$3.6B | EOG +22.7pp |
| Pre-tax income | 18.25%$1.3B | 42.90%$3.6B | EOG +24.7pp |
| Net income |
| 14.69%$1.0B |
| 33.48%$2.8B |
| EOG +18.8pp |
None
No disclosed counterparties: DVN.